WTO Rx Compulsory Licensing Agreement Solves “Symbolic” Issue, USTR Says
World Trade Organization final agreement on drug compulsory licensing represents progress on a "symbolic" issue, Assistant U.S. Trade Representative for Services, Investment and Intellectual Property James Mendenhall said Sept. 2 at an American Enterprise Institute forum on the Trade-Related Aspects of Intellectual Property Rights agreement